Risk Factors Update Summary
- Hired a new Chief Medical Officer and Chief Business Officer in 2023.
- Daily trading volume ranged from 700 to 905,600 shares in 2023.
- Options to purchase 3,423,000 common shares and 196,572 deferred stock units were added.
- Increased insurance policies, including product liability, may impact operating results.
- No longer qualify as an emerging growth company, subject to increased public company disclosure.
- Compliance with evolving environmental expectations may affect trading price of common shares.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1401040&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.